Beautiful World Pictures

The term “technology” refers to the application of knowledge for practical purposes. The field of “green technology” encompasses a continuously evolving group of methods and materials, from techniques for generating energy to non-toxic cleaning products. The present expectation is that this field will bring innovation and changes in daily life of similar magnitude to the “information technology” explosion over the last two decades. In these early stages, it is impossible to predict what “green technology” may eventually encompass.

Dynamic view of the market DJIA 8,000.86 -148.15 -1.82% NASDAQ 1,476.42 -31.42 -2.08% S&P 500 825.88 -19.26 -2.28% Q4 GDP Down 3.8 Percent, Biggest Drop Since 1982- The economy shrank at its fastest pace in nearly 27 years in the fourth quarter, government data showed, sinking deeper into recession as consumers and business cut spending. The Commerce Department on Friday said gross domestic product, which measures total goods and services output within U.S. borders, plummeted at a 3.8 percent annual rate. Analysts polled by Reuters had forecast GDP contracting 5.4 percent. http://www.schaeffersresearch.com/Default.aspx http://www.ord-oracle.com/ChartGallery1.htm

Regional Bank HOLDRS (RKH) Broker/Dealer Index (XBD SPDR HOMEBUILDERS ET(PCX: XHB The session started weak and ended the same. The Dow Jones Industrial Average (DJIA) closed at its worst levels of the day has it lost over 220 points. This more than erased yesterday's rally. The S&P 500 (SPX) and Nasdaq Composite (COMP) each lost over 3% while the Russell 2000 (RUT) dropped over 4%. Earlier we saw that the streetTRACKS Gold (GLD) and Amex Gold Bugs Index (HUI) were the only gainers and that remained true into the close. The SPDR Homebuilders (XHB), Broker/Dealer Index (XBD), and Regional Bank HOLDRS (RKH) were the weakest groups with losses in excess of 6%. http://www.amex.com/othProd/prodInf/OpPiIndMain.jsp?Product_Symbol=XBD

1/29/2009 4:58 PM The session started weak and ended the same. The Dow Jones Industrial Average (DJIA) closed at its worst levels of the day has it lost over 220 points. This more than erased yesterday's rally. The S&P 500 (SPX) and Nasdaq Composite (COMP) each lost over 3% while the Russell 2000 (RUT) dropped over 4%. http://www.schaeffersresearch.com/commentary/content/daily+wrap-up+-+a+220-point+decline+for+the+dow+jones+industrial+average/trading_floor_blog.aspx?ID=90858 http://www.schaeffersresearch.com/Default.aspx

Profit reports from U.S. Steel, American Express, chip maker Texas Instruments and movie rental company Netflix offered some assurance that the fourth quarter, though generally terrible for corporate earnings, wasn't the disaster many had feared. There were still some disappointing earnings, with shares of Delta Air Lines and Verizon Communications falling after their results fell short of Wall Street's expectations. The Dow Jones industrial average climbed 58.70 points, or 0.7%, to 8,174.73. On Monday, the index added 38 points on an increase in December of sales of existing homes. In the financial sector, Bank of America climbed 8.3% and Goldman Sachs Group gained 5.5%. An index of 24 bank stocks rose 3.4%. Shares of many banks also rose after hours on a report that next week the Obama administration might announce a plan to remove bad assets from bank balance sheets. http://www.latimes.com/business/personalfinance/la-fi-markets28-2009jan28,0,1496011.story

Friday, January 23rd 2009 Federal regulators have cleared the way for the first human trials of human embryonic stem-cell research, authorizing researchers to test whether the cells are safe to use in spinal injury patients, the company behind the trials announced Friday. The tests could begin by summer, said Dr. Thomas Okarma, president and CEO of the Geron Corporation. The Food and Drug Administration has approved the trials, which will use human stem cells authorized for research by former President George Bush in 2001. The patients will be those with the most severe spinal cord injuries, called complete spinal cord injuries. ''A complete spinal cord injury has no hope of recovery below the injury,'' Okarma told CNN. ''This is significant because it's the first clinical trial of a human embryonic-based product.'' The primary purpose of the trial will be to see whether injecting these cells into a patient is safe -- but Okarma said researchers will

Stocks slump on earnings woes GE earnings dim by 47% Conglomerate's profit comes in at low end of its expectations. Immelt expects to maintain 2009 dividend. 10:32am: Markets Last Change Dow Jones 7,959.68 -163.12 / -2.01% Nasdaq 1,455.19 -10.30 / -0.70% S&P 500 815.60 -11.90 / -1.44% 10-year Bond 109 20/32 Yield: 2.62% U.S.Dollar 1 euro = $1.281 Wall Street retreats as GE adds to gloomy corporate profit picture. Triple-digit selloff on Dow. Nasdaq off 1%, S&P 500 down 1.7%. Earnings: The week has brought a slew of weaker-than-expected earnings. Late Thursday, Advanced Micro Devices (AMD, Fortune 500) reported weaker quarterly sales and earnings that missed estimates. The company also forecast that first-quarter revenue would drop from the fourth quarter. Shares fell 3% Friday morning. http://www.latimes.com/business/investing/la-fi-markets23-2009jan23,0,1788056.story http://money.cnn.com/2009/01/23/markets/markets_newyork/index.htm?cnn=yes

Apple rises 7 percent following strong results NEW YORK (Reuters) - Apple Inc (AAPL.O) shares rose more than 7 percent on Thursday a day after it announced stronger than expected financial results and solid outlook for the current quarter despite the weak economy. Its shares rose $6.31 to $89.14 in brisk morning trade on Nasdaq as investors showed relief that demand for Apple products appeared to be holding up. While it sold fewer iPhones than expected, iPod sales beat analyst estimates. Apple's results came the night before Microsoft surprised Wall Street with a disappointing profit and said it would cut 5,000 jobs. Apple's results also contrasted sharply to consumer electronics rivals LG Electronics (066570.KS) and Sony Corp (6758.T), which posted big losses due to a slump in consumer demand for gadgets. Needham analyst Charlie Wolf said Apple results were strong even as he cut his price target for the stock to $200 from $240 and said it was clear the company was not immune t

GM's Biggest Foe Could Be Time The automaker already has received union concessions, but shareholders face dilution over how GM reduces its debt load.

Steve Jobs, chained to a rock jobs-as-prometheus2He was a Titan who stole fire from the gods and gave to mankind the tool that allowed mortals to rise above the beasts. For his sins, Jupiter had him chained to a rock on Mount Caucasus. Every day a vulture feasted on his liver, which grew back overnight. Steve Jobs, who announced on Wednesday that he is taking a medical leave to focus on his health, must feel something like poor Prometheus, chained to his rock in the hills above Palo Alto. The vultures this week are an ever-expanding team of reporters from Bloomberg News — and whoever is feeding them medical updates. On Thursday, Bloomberg reporters Connie Guglielmo, Rochelle Garner and Jason Gale wrote that Jobs could be facing surgery to remove what’s left of his pancreas, quoting a doctor in Australia who hasn’t treated Jobs and doesn’t know details of his condition. (link) On Friday, Guglielmo, joined this time by John Lauerman and Dina Bass, reported that Jobs is considering a live

Circuit City became the largest retailer to fall victim to the expanding financial crisis Friday, announcing it will shut down its remaining 567 U.S. stores at the cost of 34,000 more jobs after failing to sell the business. Two potential buyers -- Mexican billionaire Ricardo Salinas Pliego, who controls a chain of electronics stores in Latin America, and the Golden Gate Capital private equity firm -- considered a shrunken form of the business, retaining as many 350 http://www.freep.com/article/20090116/BUSINESS07/90116113/-1/rss07

Stocks tank on lousy retail sales, worries about banks Congress OKs release of final $350B of bailout Nortel files for bankruptcy A blood-red day on Wall Street ended with deep losses across the board — stocks, bond yields, oil, precious metals, the dollar. Any guesses why? The Dow Jones lost 2.9% (248 points) to close at 8,200. The S&P 500 dropped 3.3% (29 points) to 842. The Nasdaq tumbled 3.6% (56 points) to 1,489. The Russell 2000 swooned 4.3% (20 points) to 453. Briefing.com noted with an hour to go that roughly 93% of the companies in the S&P 500 were in the red, as were all 30 components of the Dow. The day's pile driver? The Commerce Department's report showing retail sales in December dropped 2.7%. Analysts had predicted a 1.2% decline. It was the sixth-straight monthly decline, a record. Don't forget the main pillar of our way of life: "Consumer spending accounts for more than two-thirds of U.S. economic activity." Another daily downer for invest

Bernanke: Government Actions Key to Recovery. World markets tumble on US earnings concerns. Stocks Sink After Retail Sales Report- AP Wall Street stocks down sharply in early trading. The Commerce Department has reported that retail sales fell twice as much as expected during December. Retail sales fell for a sixth consecutive month registering a sharp 2.7% decline in December. Meanwhile, oil prices fell below $38 a barrel due to worries of weak demand. The Dow tumbled nearly 180 points to 8270 while Nasdaq plunged 30 points to 1514. http://investor.biospace.com/biospace?Page=QUOTE&Ticker=NUVA

Stock futures flat ahead of Alcoa report Proves false prediction. Actually it dropped. Wall Street appears headed for flat opening as investors await earnings report from Alcoa Oil falls below $39 as investors look to US earnings for clues on crude demand J.P. Morgan expects biotechnology executives to express optimism about their companies' prospects in 2009 during presentations at the bank's 27th annual health care conference in San Francisco. Companies attending the conference include Amgen Inc., Genentech Inc. and Biogen Idec Inc. Market Recap Stocks are down sharply as investors liquidate holdings across the board. The Dow Industrials are down -1.22% to 8,494. Things are more stable in the bond market, with the benchmark 10-year Treasury Bond higher, its yield dropping to 2.35%. The Energy and Materials sectors are the biggest laggards, down -3.52% and -3.47% respectively. http://www.djindexes.com/

Encourage The Advertisers

TIENS BIOTECH GROUP USA INC COM TBV: AMEX Tiens Biotech Group (USA), Inc. (Tiens USA) researches, develops, manufactures, and markets nutrition supplement products, including wellness products and dietary supplement products. The Company's operations are conducted from its headquarters in Tianjin, People's Republic of China through Tiens USA's 80% owned subsidiary, Tianjin Tianshi Biological Development Co., Ltd. The Company sells its products for distribution in China to Tianshi Engineering, an affiliated Chinese firm, which in turn sells the products to customers through its branches and affiliated companies and at chain stores owned by individual distributors. As of December 31, 2007, Tianshi Engineering had 100 branches in China. Outside of China, Tiens USA sells its products to overseas affiliated companies located in 52 countries that in turn sell them to independent direct sales distributors who use the products themselves and/or resell them to other distributors or

What is osteoarthritis? ANIKA THERAPEUTICS INC COM ANIK : NASDAQ Osteoarthritis is a type of arthritis that is caused by the breakdown and eventual loss of the cartilage of one or more joints. Cartilage is a protein substance that serves as a "cushion" between the bones of the joints. Osteoarthritis is also known as degenerative arthritis. Among the over 100 different types of arthritis conditions, osteoarthritis is the most common, affecting over 20 million people in the United States. Osteoarthritis occurs more frequently as we age. Before age 45, osteoarthritis occurs more frequently in males. After age 55 years, it occurs more frequently in females. In the United States, all races appear equally affected. A higher incidence of osteoarthritis exists in the Japanese population, while South African blacks, East Indians, and Southern Chinese have lower rates. http://www.medicinenet.com/osteoarthritis/article.htm#Whatis

Google Ads

Miners lead in Asia as metal prices jump By Rosalind Mathieson, Dow Jones Newswires Last update: 10:16 p.m. EST Jan. 6, 2009 SINGAPORE (Dow Jones)--Asian shares were higher Wednesday after another gain on Wall Street, with mining stocks powering ahead on a recovery in prices for base metals and gold. Technology stocks were also faring well in Japan, Korea and Taiwan amid hopes for a rebound in prices for memory chips. Analysts pointed to continued inflows of funds to stocks for the new year, even though they cautioned that strong economic headwinds remained; "there's been a lot of portfolio buying and asset allocation coming back into the market," said George Kanaan, head of sales in Sydney at UBS.

January-06 2009 Stock Futures Regain Momentum Ahead of Data- 05 00 am On track toward higher open Wall Street headed for a moderately higher open Tuesday, regaining its upward momentum ahead of a fresh round of readings on the service sector, factory orders and pending home sales. LUV] Southwest Airlines December load factor 69.7% vs. 68.2% OREX Orexigen Therapeutics, Inc. NASDAQ-GM Huckman ticked off some names like Gilead Sciences (GILD) and Onyx Pharmaceuticals (ONXX). Hickma said to look out for a company called Orexigen Therapeutics (OREX), which, he said, is coming out this week or next with the first data on late-stage results of a weight-loss drug. http://www.marketwatch.com/ http://www.nasdaq.com/aspxcontent/NewsStory.aspx?cpath=20090105/fast_money_back_to_reality_29791.html&symbol=OREX&selected=OREX&selecteddisplaysymbol=OREX&coname=Orexigen%20Therapeutics,%20Inc.&logopath=%2flogos%2fOREX.GIF&market=NASDAQ-GM&pageName=Company%20News&mypage=com

Barchart.com - Signals - Top 100 Stocks Showing 1 - 50, for Jan 5 Symbol Company Name Exch Last Change Today's Opinion Yesterday's Opinion Last Week's Opinion Last Month's Opinion TBV TIENS BIOTECH GR USA AMEX 2.28 +0.25 100% Buy 100% Buy 64% Buy 88% Buy TIS ORCHIDS PAPER PROD AMEX 9.40 -0.10 100% Buy 100% Buy 88% Buy 40% Buy FHC FEMALE HEALTH CO AMEX 4.35 +0.39 88% Buy 88% Buy 24% Buy Hold AVAV AEROVIRONMENT INC. NASD 39.38 +1.12 100% Buy 100% Buy 16% Buy 56% Sell TWGP TOWER GROUP INC. NASD 28.74 +0.84 100% Buy 100% Buy 80% Buy 40% Buy CYPB CYPRESS BIOSCIENCE I NASD 8.00 +0.52 88% Buy 88% Buy 64% Buy 56% Sell VSEC VSE CORPORATION NASD 42.34 +2.53 100% Buy 80% Buy 40% Buy 48% Buy RPRX REPROS THERAPEUTICS NASD 11.46 +0.56 100% Buy 96% Buy 88% Buy 40% Buy CHSCP CHS INC NASD 25.50 +0.15 100% Buy 96% Buy 64% Buy 40% Buy OCN OCWEN FINL CORP NYSE 9.15 +0.04 100% Buy 100% Buy 48% Buy 64% http

Date Open High Low Last Change % Change 01/05/09 9027.13 9034.37 8892.36 8952.89 -81.80 -0.91% Composite Indicator Trend Spotter TM Hold Short Term Indicators 7 Day Average Directional Indicator Buy 10 - 8 Day Moving Average Hilo Channel Buy 20 Day Moving Average vs Price Buy 20 - 50 Day MACD Oscillator Buy 20 Day Bollinger Bands Hold http://quote.barchart.com/texpert.asp?sym=$DOWI&code=BSTK

Weekly Date Open High Low Last Change % Change 01/05/09 9027.13 9034.37 8892.36 8952.89 -81.80 -0.91% 12/29/08 8515.87 9065.28 8364.06 9034.69 +519.14 +6.10% 12/22/08 8573.37 8604.12 8372.02 8515.55 -63.56 -0.74% 12/15/08 8628.81 8961.26 8469.03 8579.11 -50.57 -0.59% 12/08/08 8637.65 9026.41 8347.81 8629.68 -5.74% Monthly 01/01/09 8772.25 9065.28 8760.78 8952.89 +176.50 +2.01% 12/01/08 8826.89 9026.41 8118.50 8776.39 -52.65 -0.60% 11/01/08 9326.04 9653.95 7449.38 8829.04 -495.97 -5.32% 10/01/08 10847.40 10882.52 7882.51 9325.01 -1525.65 -14.06% 09/01/08 11545.63 11790.17 10365.45 10850.66 -692.89 -6.00% http://quote.barchart.com/quote.asp?sym=$DOWI&code=BSTK&dwm=w

S&P futures vs fair value: +1.90. Nasdaq futures vs fair value: +4.50. The major indices are positioned to start the first trading session of 2009 flat-to-modestly higher, according to stock futures. Energy is expected to be an early laggard as crude oil futures run into selling pressure. Losses in crude prices are being pared, however. Oil has rallied roughly $2 per barrel in the last half hour to trade 1% lower at $44 per barrel. Close DJIA 9,034.69 258.30 2.94% NASDAQ 1,632.21 55.18 3.50% S&P 500 931.80 28.55 3.16% 10yr Note 111.969 -1.2188 1.08% Gold 879.50 -4.80 0.54% The Dow Jones rose 2.9% (258 points) to end the first session of 2009 at 9,034; the S&P 500 climbed 3.1% (28 points) to finish at 931; the Nasdaq closed even higher — 3.5% — at 1,632; and the Russell 2000 small-cap stocks inched up just 1.3% to 506. Elsewhere, General Motors advanced 14.1 per cent to $3.65 after the car group received the first $4bn in aid from the US Treasury that is designed to stav